We briefly review the research ” ‘Good’ bacteria is potential solution to unchecked inflammation seen in bowel diseases ” in regard to helping the two most common inflammatory bowel diseases, Crohn’s disease and ulcerative colitis. Citation Tile: NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nature Immunology, 2017; DOI: 10.1038/ni.3690